Anja C. Mortensen

Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells

Sara Häggblad Sahlberg, Anja C. Mortensen, Jakob Haglöf et al. · International Journal of Oncology · 2016 · 79 citations · Full text

Medicine, Molecular Biology, Oncology +17

The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells

Diana Spiegelberg, Adrian Dascalu, Anja C. Mortensen et al. · Oncotarget · 2015 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors

Diana Spiegelberg, Anja C. Mortensen, Sara Lundsten et al. · Cancer Research · 2018 · 41 citations

Medicine, Oncology, Radiation Oncology +14

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

Diana Spiegelberg, Andris Abramenkovs, Anja C. Mortensen et al. · Scientific Reports · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +13

Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib

Anja C. Mortensen, Tabassom Mohajershojai, Mehran Hariri et al. · Frontiers in Oncology · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +15